Kevin R. Sayer - Nov 15, 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Signature
By: Jereme Sylvain For: Kevin R Sayer
Stock symbol
DXCM
Transactions as of
Nov 15, 2021
Transactions value $
-$1,943,515
Form type
4
Date filed
11/16/2021, 12:11 PM
Previous filing
Oct 18, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Gift $0 -3K -3.31% $0.00 87.7K Nov 12, 2021 Direct F1, F2
transaction DXCM Common Stock Sale -$143K -222 -0.25% $644.59 87.5K Nov 15, 2021 Direct F2, F3, F4
transaction DXCM Common Stock Sale -$161K -250 -0.29% $645.01 87.2K Nov 15, 2021 Direct F2, F3, F5
transaction DXCM Common Stock Sale -$129K -200 -0.23% $646.58 87K Nov 15, 2021 Direct F2, F3, F6
transaction DXCM Common Stock Sale -$875K -1.35K -1.55% $647.92 85.7K Nov 15, 2021 Direct F2, F3, F7
transaction DXCM Common Stock Sale -$570K -878 -1.02% $649.02 84.8K Nov 15, 2021 Direct F2, F3, F8
transaction DXCM Common Stock Sale -$32.6K -50 -0.06% $652.36 84.8K Nov 15, 2021 Direct F2, F3
transaction DXCM Common Stock Sale -$32.7K -50 -0.06% $654.00 84.7K Nov 15, 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction represents a gift by the Reporting Person of 3,000 shares to a charitable donor advised fund.
F2 Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
F3 On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F4 This transaction was executed in multiple trades at prices ranging from $643.86 to $644.68. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 This transaction was executed in multiple trades at prices ranging from $644.99 to $645.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F6 This transaction was executed in multiple trades at prices ranging from $646.57 to $646.58. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F7 This transaction was executed in multiple trades at prices ranging from $647.64 to $648.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F8 This transaction was executed in multiple trades at prices ranging from $648.64 to $649.475. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.